⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL386857 | 1.00 | — | — | |
| SCHEMBL16797521 | 1.00 | — | — | |
| SCHEMBL503840 | 0.79 | — | — | |
| SCHEMBL503841 | 0.79 | — | — | |
| SCHEMBL14394636 | 0.79 | — | — | |
| SCHEMBL1014134 | 0.75 | — | — | |
| SCHEMBL12282126 | 0.75 | — | — | |
| SCHEMBL6753566 | 0.75 | — | — | |
| SCHEMBL1016595 | 0.75 | — | — | |
| SCHEMBL16167731 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11896593-B2 | Sulfamate derivative compounds for use in treating or alleviating a psychiatric disorder | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2024-02-13 | — | — | US | disclosed |
| EP-4211125-A1 | SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING A PSYCHIATRIC DISORDER | Bio-Pharm Solutions Co., Ltd. (KR) | 2023-07-19 | — | — | EP | disclosed |
| CN-116234798-A | Sulfamate derivative compounds for the treatment or alleviation of psychotic disorders | 生物药品解决方案有限公司 | 2023-06-06 | — | — | CN | disclosed |
| US-20220218702-A1 | SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING A PSYCHIATRIC DISORDER | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2022-07-14 | — | — | US | disclosed |
| CN-106507667-B | Sulfamate derivatives for the prevention or treatment of epilepsy | 比皮艾思药物研发有限公司 | 2020-01-24 | — | — | CN | disclosed |
| EP-3443959-A1 | SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN | Bio-Pharm Solutions Co., Ltd. (KR) | 2019-02-20 | — | — | EP | disclosed |
| EP-3079685-B1 | SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN | BIO PHARM SOLUTIONS CO LTD (KR) | 2018-11-28 | — | — | EP | disclosed |
| EP-3079686-B1 | SULFAMATE DERIVATIVE COMPOUND FOR USE IN PREVENTING OR TREATING EPILEPSY | BIO PHARM SOLUTIONS CO LTD (KR) | 2018-10-24 | — | — | EP | disclosed |
| US-10081615-B2 | Sulfamate derivative compounds for use in treating or alleviating pain | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2018-09-25 | — | — | US | disclosed |
| US-9937145-B2 | Sulfamate derivative compound for use in preventing or treating epilepsy | BIO-PHARM SOLUTIONS CO., LTD. (KR) | 2018-04-10 | — | — | US | disclosed |
| WO-2002088065-A1 | PROCESS FOR THE PREPARATION OF KETONES | DEGUSSA AG (DE) | 2002-11-07 | — | — | WO | disclosed |
| US-20020161263-A1 | Process for the preparation of ketones | DEGUSSA AG (DE) | 2002-10-31 | — | — | US | disclosed |
| US-6380437-B1 | REACTING A TERTIARY PROPARGYL ALCOHOL WITH ALKENYL ALKYL ETHER OR KETAL; HEATING, PRESSURIZATION IN PRESENCE OF SULFONIC ACID | DEGUSSA AG (DE) | 2002-04-30 | — | — | US | disclosed |
| EP-1092700-A1 | Process for the preparation of unsaturated 4,5-allene ketones, 3,5-dienketones and the corresponding saturated ketones | Degussa-Hüls Aktiengesellschaft (DE) | 2001-04-18 | — | — | EP | disclosed |
| US-6034279-A | REACTIG A TERTIARY ALLYL ALCOHOL WITH A ALKEYL ETHER I PRESECE OF ACID CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 2000-03-07 | — | — | US | disclosed |
| EP-0897380-A1 | METHOD FOR THE PRODUCTION OF $g(g), $g(d)-UNSATURATED KETONES BY REACTING TERTIARY ALLYL ALCOHOLS WITH ALKENYL ALKYL ETHERS | BASF AKTIENGESELLSCHAFT (DE) | 1999-02-24 | — | — | EP | disclosed |
| WO-1998023570-A1 | METHOD FOR THE PRODUCTION OF η, δ-UNSATURATED KETONES BY REACTING TERTIARY ALLYL ALCOHOLS WITH ALKENYL ALKYL ETHERS | BASF AKTIENGESELLSCHAFT (DE) | 1998-06-04 | — | — | WO | disclosed |
| EP-0272110-B1 | ERYTHROMYCIN A DERIVATIVES AND METHOD FOR THE PREPARATION OF THE SAME | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1993-04-07 | — | — | EP | disclosed |
| US-4990602-A | Bactericides | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1991-02-05 | — | — | US | disclosed |
| EP-0272110-A2 | Erythromycin a derivatives and method for the preparation of the same | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1988-06-22 | — | — | EP | disclosed |